RecruitingNCT06833593

Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia

Efficacy of Optimized Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia and Identification of Intestinal Microbiota Signature

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

510 participants

Start Date

Feb 6, 2021

Study Type

OBSERVATIONAL

Conditions

Blood Stream Infection Gut Microbiomes Enterococcus Faecalis Infection

Summary

Prospective, multicenter, national, observational pharmacological study on the evaluation of efficacy of appropriate monotherapy vs combination treatment for non-complicated Enterococcus faecalis (EF) bloodstream infection (BSI) and identification of gut microbiota fingerprint of patients with EF-BSI correlated to antimicrobial treatment and clinical outcome

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with blood stream infection, enterococcus faecalis infection, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.